Suchergebnisse - "Weis, Nina"

PubPharm (33)

1

Peer-delivered point-of-care testing and linkage to treatment for hepatitis C virus infection among marginalized populations through a mobile clinic in Copenhagen, Denmark

enthalten in: The International journal on drug policy | 2023

von Demant, J. | Krohn-Dehli, L. | Van der Veen, J. | +3

2

Pre-existing, treatment-specific resistance-associated substitutions in hepatitis C virus genotype 1 and 3 and viral RNA titers during treatment with direct-acting antivirals

enthalten in: APMIS : acta pathologica, microbiologica, et immunologica Scandinavica | 2023

von Sølund, C. | Pedersen, M. | Fahnøe, U. | +5

3

Novel HCV Genotype 4d Infectious Systems and Assessment of Direct-Acting Antivirals and Antibody Neutralization

enthalten in: Viruses | 2022

von Pham, L. | Velázquez-Moctezuma, R. | Fahnøe, U. | +7

4

Myocardial perfusion reserve in patients with chronic hepatitis C before and after direct-acting antiviral treatment-a pilot study

enthalten in: Clinical physiology and functional imaging | 2022

von Sølund, C. | Hasbak, P. | Knudsen, A. | +3

5

Novel hepatitis B virus reverse transcriptase mutations in patients with sustained viremia despite long-term tenofovir treatment

enthalten in: Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology | 2022

von Winckelmann, A. | Fahnøe, U. | Bajpai, P. | +5

6

The antiviral targeting potential of viroporins

enthalten in: Ugeskrift for laeger | 2022

von Sund, J. | Bollerup, S. | Glamann, J. | +7

7

The European Prevalence of Resistance Associated Substitutions among Direct Acting Antiviral Failures

enthalten in: Viruses | 2021

von Popping, S. | Cento, V. | Seguin-Devaux, C. | +14

8

Overcoming Culture Restriction for SARS-CoV-2 in Human Cells Facilitates the Screening of Compounds Inhibiting Viral Replication

enthalten in: Antimicrobial agents and chemotherapy | 2021

von Ramirez, S. | Fernandez-Antunez, C. | Galli, A. | +13

9

Global evolutionary analysis of chronic hepatitis C patients revealed significant effect of baseline viral resistance, including novel non-target sites, for DAA-based treatment and retreatment outcome

enthalten in: Journal of viral hepatitis | 2021

von Fahnøe, U. | Pedersen, M. | Sølund, C. | +12

10

The Copenhagen test and treat hepatitis C in a mobile clinic study : a protocol for an intervention study to enhance the HCV cascade of care for people who inject drugs (T'N'T HepC)

enthalten in: BMJ open | 2020

von Lazarus, J. | Øvrehus, A. | Demant, J. | +2